[1] 沈文静,刘石磊,邱广蓉.zebularine对卵巢癌细胞的生长抑制作用[J].东南大学学报:医学版,2011,30(4):545-549.
[2] 王可可,吴宜林.MG132联合顺铂对人宫颈癌HeLa细胞裸鼠移植瘤的影响[J].现代医学,2012,40(2):137-141.
[3] 董伟民,曹祥山,凌云,等.氨磷汀在异基因造血干细胞移植预处理中的保护作用[J].现代医学,2011,39(1):71-73.
[4] LODISH H,BERK A,ZIPURSKY L S,et al.Molecular cell biology[M].NewYork:W H Freeman and Company,2002.
[5] ZHANG S.Beyond the Petri dish [J].Nat Biotech,2004,22:151-152.
[6] ABBOTT A.Cell culture:biology's new dimension[J].Nature,2003,424:870-872.
[7] CUKIERMAN E,PANKOV R,STEVENS D R,et al.Taking cell-matrix adhesions to the third dimension[J].Science,2001,294:1708-1710.
[8] BISSELL M J,RIZKI A,MIAN I S.Tissue architecture:the ultimate regulator of breast epithelial function[J].CurrOpin Cell Biol,2003,(15):753-755.
[9] EVEN-RAM S,YAMADA K M.Cell migration in 3Dmatrix[J].CurrOpin Cell Biol,2005,(7):524-525.
[10] MUSCHLER G F,NAKAMOTO C,GRIFFITH L G.Engineering principles of clinical cell-based tissue engineering[J].Bone Joint Surg Am,2004,86:1541-1542.
[11] GARTNER L P,HIATT J L.Color textbook of histology[M].Philadelphia:Saunders,2001.
[12] HOLLISTER S J,LEVY R A,CHU T M,et al.An image- based approach for designing and manufacturing craniofacial scaffolds[J].Int J Oral Max Surg,2000,29:67-68.
[13] TALA A,BAUER S B,SOKER S,et al.Tissue-engineered autologous bladders for patients needing cystoplasty[J].Lancet,2006,367:1241-1243.
[14] PALSSON B,HUBBELL J A,PLONSEY R,et al.Tissue engineering[M].Boca Raton,FL:CRC Press,2003:101-110.
[15] GOMEZ N,LU Y,CHEN S,et al.Immobilized nerve growth factor and microtopography have distinct effects on polarization versus axon elongation inhippocampal cells in culture[J].Biomaterials,2007,28:271-275.
[16] ZHU X,MILLS K L,PETERS P R,et al.Fabrication of reconfigurable protein matrices bycracking[J].Nat Mater,2005,4:403-405.
[17] BIOSCIENCE B D.Lactate dehydrogenase elevating virus.-08-17].http://www.bdbiosciences.com.
[18] ZHANG S.Hydrogels:wet or let die[J].Nat Mater,2004,3:7-9.
[19] DRURY J L,MOONEY D J.Hydrogels for tissue engineering:scaffold design variables and applications[J].Biomaterials,2003,24:4337-4340.
[20] RABIN O,MANUEL PEREZ J,GRIMM J,et al.An X-ray computed tomography imagingagent based on long-circulating bismuth sulphide nanoparticles[J].Nat Mater,2006,5:118-122.
[21] SUMING L.Hydrolytic degradation characteristics of aliphaticpolyesters derived from lactic and glycolic acids[J].Biomed Mater Res,1999,48:342-346.
[22] ADACHI T,OSAKO Y,TANAKA M,et al.Framework for optimal design of porous scaffold microstructureby computational simulation of bone regeneration [J].Biomaterials,2006,27:3964-3969.
[23] CADEE J A,van LUYN M J,BROUWER L A,et al.In vivo biocompatibility of dextran-based hydrogels[J].Biomed Mater Res,2000,50(3):397-404.
[24] CHEN F M,ZHAO Y M,SUN H H,et al.Novel glycidylmethacrylated dextran (Dex-GMA)/gelatin hydrogel scaffolds containing microspheres loaded with bone morphogenetic proteins:formulation and characteristics[J].Controlled Release,2007,118(1):65-77.
[25] De SMEDT S C,LAUWERS A,DEMEESTER J.Characterization of the network structure of dextran glycidyl methacrylate hydrogels by studying the rheological and swelling behavior[J].Macromolecules,1995,28(14):5082-5088.
[26] ITO T,YEO Y,HIGHLEY C B,et al.Dextran-based in situ cross-linkedinjectable hydrogels to prevent peritoneal adhesions[J].Biomaterials,2007,28(23):3418-3426.
[27] LIU Y X, CHANPARK M B. A biomimetic hydrogel based on methacrylated dextran-graft-lysine and gelatin for 3D smooth muscle cell culture[J].Biomaterials,2010,31:1158-1170.
[28] CAI Q,YANG J,BEI J Z,et al.Center for Molecular Sciences,Institute of Chemistry.Chinese Academy of Sciences,Beijing 100080,2002,23:4483-4492.
[29] STEPHANE G.Levesque,synthesis of cell-adhesive dextran hydrogels and macroporous scaffolds[J].Biomaterials,2006,27:5277-5285.
[30] MAGNUSSON A C,LUNDSTROM T.Propagation of influenza virus in vero cells using CytodexTM microcarriers in WAVE systems.2011,ACS spring meeting.
[31] 肖飞,董晶.温度敏感葡聚糖凝胶的合成及其细胞相容性研究[J].功能材料,2007,28:1835-1837.
[32] KAPLAN D L,MOON R T,VUNJAK-NOVAKOVIC G.Ittakes a village to grow a tissue[J].Nat Biotech,2005,23:1237-1240.
[33] LIAO E,YASZEMSKI M,KREBSBACH P,et al.Tissue-engineered cartilage constructs using composite hyaluronicacid/collagen I hydrogels and designed poly(propylenefumarate) scaffolds[J].Tissue Eng,2007,13:537-541.
[34] XU J,MA M,PURCELL W M.Characterisation of somecytotoxic endpoints using rat liver and HepG2 spheroids asin vitro models and their application in hepatotoxicitystudies Ⅱ Spheroid cell spreading inhibition as a new cytotoxicmarker[J].ToxicolAppl Pharm,2003,189:112-116.
[35] MACNEIL S.Progress and opportunities for tissue-engineeredskin[J].Nature,2007,445:874-875.
[36] The Interagency Coordinating Committee on the Validationof Alternative Methods,2004 (on-line).Available at http://iccvam.niehs.nih.gov.Accessed on 02/17/08.
[37] MOUTOS F T,FREED L E,GUILAK F.A biomimetic three-dimensional woven composite scaffold for functionaltissue engineering of cartilage[J].Nat Mater,2007,6:162-165.
[38] WILSON A,TRUMPP A.Bone-marrow haematopoieticstem-cell niches[J].Nat Rev Immunol,2006,6:93-95. |
